University of Houston researchers make nasal vaccine that prevents COVID from spreading

A team of researchers from the University of Houston have developed a new vaccine to treat and prevent the spread of flu and multiple coronavirus strains.

SARS-CoV-2, University of Houston, Omnicron, Pfizer, Delta, cGAMP, FDA, Navin Varadarajan, NanoSTING-SN, Ankita Leekha, COVID, Houston, Methodist, Russian, NanoSTING, AuraVax Therapeutics, Translational Human Infectious Diseases, Moderna, Laboratory of Human Molecular, Nature Communications, TamifluReadArchived

Through two nasal sprays — an immune activating therapeutic treatment and a new vaccine — the team of UH researchers have not only broken ground on vaccinating against SARS-CoV-2 and the flu virus, but also on creating a universal coronavirus vaccine.